Roche is acquiring Poseida Therapeutics, a biotech developing allogeneic cell therapies for cancers and immunological indications. The two companies have been partners in hematological malignancies since 2022. The post Roche Expands Its Scope in Allogeneic Cell Therapy With $1B Poseida Therapeutics Acquisition appeared first on MedCity News.
This fact sheet provides an overview of U.S. government global health policy and engagement.
This story describes a lethal injection procedure used in state executions. In May, a group of healthcare workers spent about an hour trying to establish complete IV access so they could inject Tony Carruthers, an inmate at the Riverbend Maximum Security Institution in Nashville, Tennessee, with a lethal dose of sedative. Maria DeLiberato, an attorney…
We’re looking for biopharma startups focused on infectious diseases, medtech/diagnostics startups supporting chronic disease management, and health tech startups seeking to improve care navigation and coordination and developing AI tech. The post Attention Healthcare and Life Science Startups: Deadline for INVEST Pitch Perfect Contest Submissions is Feb 21 appeared first on MedCity News.
WASHINGTON, DC — Cada noche, Abdullah Ibrahim se retira de las calles hacia un área boscosa junto al río Potomac. Cuando cae la noche y bajan las temperaturas, arma una tienda de campaña y enciende una fogata bajo un grupo de pinos, abetos y cedros. Evita a las autoridades rotando el uso de tres tiendas…
BioCryst Pharmaceuticals’ Astria Therapeutics acquisition brings navenibart, a drug in Phase 3 testing for the rare disease hereditary angioedema. The injectable antibody has the potential to match the efficacy of the blockbuster Takeda Pharmaceutical drug that currently dominates the market, but with less burdensome dosing that could encourage HAE patients to switch. The post BioCryst’s…
This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence misinformation and AI’s role in spreading false mental health information.
The specialty access and capacity crisis demands more than incremental fixes. It requires expanding virtual access and fundamentally rethinking how specialty care can be delivered. The post Virtual Specialty Care Has Time. Will We Use It Wisely? appeared first on MedCity News.
Is homelessness a mental health and addiction crisis, or is it driven by an affordable housing crisis? That question underpins the debate among policymakers and politicians struggling to move people off the streets faster than they become homeless. Researchers say housing is the most important intervention to end homelessness, and now a report from the…
Saniona’s drug candidate could expand Jazz Pharmaceuticals portfolio in epilepsy. But this preclinical small molecule will need to show advantages in safety and efficacy to compete with Biohaven Pharmaceuticals and Xenon Pharmaceuticals, each with clinical-stage drugs that hit the same epilepsy target. The post Jazz Pharma Broadens Its Prospects in Epilepsy With Deal for Selective…